Bayer CropScience Ltd files Reg 29(1) disclosure on share acquisition by Bayer AG and PACs

What Bayer CropScience Ltd announced

On 10 July 2026, Bayer CropScience Ltd (BSE: 506285) filed a disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing states that Bayer AG and its Persons Acting in Concert (PACs) have undertaken a substantial acquisition of shares in Bayer CropScience Ltd. No further quantitative details – such as the number of shares acquired, the percentage of total equity, or the consideration paid – were included in the notice.

Details of the Reg 29(1) filing

• Filing date and time: 10 July 2026, 09:44:04 UTC
• Exchange: Bombay Stock Exchange (BSE)
• Company: Bayer CropScience Ltd (BSE code 506285)
• Subject of filing: Disclosure under Regulation 29(1) of SEBI (SAST) Regulations, 2011 for Bayer AG & PACs
• Content of filing: A brief statement confirming that a substantial share acquisition has taken place. The filing does not provide the size of the stake, the price paid, or any conditions attached to the transaction.

About Regulation 29(1) of SEBI SAST Regulations

Regulation 29(1) mandates that any person or group of persons (including PACs) who acquire shares that cause their holding to cross any of the prescribed thresholds – typically 5%, 10%, 15%, 20%, 25%, 30%, 50% and 75% of the voting share capital – must immediately disclose the acquisition to the stock exchange. The disclosure must contain:

• The identity of the acquirer(s)
• The number of shares acquired and the resulting percentage of total equity
• The consideration paid (cash, securities, or other assets)
• Any agreements or arrangements that may affect control of the company The purpose of the regulation is to ensure transparency for investors and to prevent covert takeovers.

Background on Bayer CropScience Ltd and Bayer AG

Bayer CropScience Ltd is the Indian subsidiary of Bayer AG, a global life‑science company headquartered in Germany. The CropScience business focuses on seeds, traits, and crop protection chemicals, serving Indian farmers across major agronomic segments. Bayer AG holds a controlling stake in the Indian entity, and the two companies operate under a shared strategic vision for agricultural innovation.

The term PACs (Persons Acting in Concert) refers to individuals or entities that agree to act together in acquiring, holding, or disposing of shares. In practice, PACs can include subsidiaries, affiliates, senior management, or other related parties that coordinate their shareholding decisions. The filing specifically mentions “Bayer AG & PACs,” indicating that the parent company and one or more related parties have collectively increased their shareholding in the Indian subsidiary.

Key facts at a glance

Why this matters for investors

The filing confirms that Bayer AG, together with related parties, has increased its stake in Bayer CropScience Ltd to a level that triggers a mandatory disclosure under SEBI rules. For existing shareholders, this signals a potential consolidation of control by the parent company. While the notice does not reveal the exact size of the new holding, the requirement to file under Reg 29(1) implies that the combined shareholding has crossed at least one of the regulatory thresholds (commonly 5% or higher). Investors should monitor subsequent disclosures, as SEBI may require further filings if the stake crosses additional thresholds or if any agreements affecting control are entered into.

The absence of quantitative details means that the immediate impact on share dilution, voting power, or dividend entitlement cannot be quantified at this stage. However, the filing does provide regulatory assurance that the acquisition has been reported in a timely manner, enhancing market transparency.

Conclusion

Bayer CropScience Ltd’s Reg 29(1) filing on 10 July 2026 confirms that Bayer AG and its PACs have made a substantial share acquisition, though the exact size and terms of the transaction remain undisclosed. The filing satisfies SEBI’s disclosure obligations and alerts investors to a possible shift in the ownership structure of the company. Further details are expected to be released in subsequent filings if additional thresholds are crossed or if any binding agreements are executed.